COBITOLIMOD FOR USE IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
The present invention provides an oligonucleotide comprising the sequence 5'-GGAACAGTTCGTCCATGGC-3' (SEQ ID NO:2) for use in the treatment of inflammatory bowel disease in a human subject, wherein individual doses of from 150mg to 350mg of said oligonucleotide are administered to the subje...
Saved in:
| Main Authors | , , , , |
|---|---|
| Format | Patent |
| Language | Chinese English |
| Published |
10.01.2020
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention provides an oligonucleotide comprising the sequence 5'-GGAACAGTTCGTCCATGGC-3' (SEQ ID NO:2) for use in the treatment of inflammatory bowel disease in a human subject, wherein individual doses of from 150mg to 350mg of said oligonucleotide are administered to the subject on at least two separate occasions, wherein said separate occasions are 3 weeks apart.
本发明提供了包含序列5'-GGAACAGTTCGTCCATGGC-3'(SEQ ID NO:2)的寡核苷酸在治疗人类受试者的炎症性肠病中的应用，其中在至少两次分开的场合下，向受试者给药单次剂量为150mg至350mg的所述寡核苷酸，其中所述分开的场合相隔3周。 |
|---|---|
| AbstractList | The present invention provides an oligonucleotide comprising the sequence 5'-GGAACAGTTCGTCCATGGC-3' (SEQ ID NO:2) for use in the treatment of inflammatory bowel disease in a human subject, wherein individual doses of from 150mg to 350mg of said oligonucleotide are administered to the subject on at least two separate occasions, wherein said separate occasions are 3 weeks apart.
本发明提供了包含序列5'-GGAACAGTTCGTCCATGGC-3'(SEQ ID NO:2)的寡核苷酸在治疗人类受试者的炎症性肠病中的应用，其中在至少两次分开的场合下，向受试者给药单次剂量为150mg至350mg的所述寡核苷酸，其中所述分开的场合相隔3周。 |
| Author | KNITTEL THOMAS SANDWALL PERNILLA ZERHOUNI PETER ADMYRE CHARLOTTE ZARGARI AREZOU |
| Author_xml | – fullname: SANDWALL PERNILLA – fullname: KNITTEL THOMAS – fullname: ADMYRE CHARLOTTE – fullname: ZARGARI AREZOU – fullname: ZERHOUNI PETER |
| BookMark | eNrjYmDJy89L5WRwcvZ38gzx9_H09XdRcPMPUggNdlXw9FMI8XBVCAlydQzxdfULUfB3A4q5-Tj6-jqG-AdFKjj5h7v6KLh4Brs6BrvyMLCmJeYUp_JCaW4GRTfXEGcP3dSC_PjU4oLE5NS81JJ4Zz9DQwMzcwtDCwtHY2LUAAANEizr |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | 可比托莫德在治疗炎症性肠病中的应用 |
| ExternalDocumentID | CN110678188A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_CN110678188A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 14:19:23 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | Chinese English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_CN110678188A3 |
| Notes | Application Number: CN201880031203 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200110&DB=EPODOC&CC=CN&NR=110678188A |
| ParticipantIDs | epo_espacenet_CN110678188A |
| PublicationCentury | 2000 |
| PublicationDate | 20200110 |
| PublicationDateYYYYMMDD | 2020-01-10 |
| PublicationDate_xml | – month: 01 year: 2020 text: 20200110 day: 10 |
| PublicationDecade | 2020 |
| PublicationYear | 2020 |
| RelatedCompanies | INDEX PHARMACEUTICALS AB |
| RelatedCompanies_xml | – name: INDEX PHARMACEUTICALS AB |
| Score | 3.3678937 |
| Snippet | The present invention provides an oligonucleotide comprising the sequence 5'-GGAACAGTTCGTCCATGGC-3' (SEQ ID NO:2) for use in the treatment of inflammatory... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | COBITOLIMOD FOR USE IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200110&DB=EPODOC&locale=&CC=CN&NR=110678188A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH9BNOpNUYP4kZqY3RaBfbHDYrauCxhYCSuKJ7JuLOoBiMyY-NfbNiBe9Na8Ji-vTX59H-37FeDWamczu5PbumEZTd1Muanz1Cl0nhlWx5U9aYV65Rvb3bH5MLEmFXjb9MIontBPRY4oEJUJvJfqvF5ui1ihelu5uuOvQrS4j5gXauvsuK0o0LQw8MiQhhRrGHs41uKR15JUacI5dfwd2BVhtCPRQB4D2ZWy_O1SoiPYGwpt8_IYKl8vNTjAm5_XarA_WF94i-Eae6sTCDANeoyK04aGSORuaJwQ1IsR6xLERsRnkpYf0UjIor4_GPiMjp5RQJ9IH4W9hPgJOYWbiDDc1YUx05-VT3G8tds4g-p8MZ_VARVO7mROVpi565rNzEpzedmYuiLYyNvc4OfQ-FtP47_JCziUuyhrDK3mJVTL94_ZlfC6Jb9W2_UNd6mAEQ |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD7MKc43nYrOWwTpW3HrZV0firRpSqttM7ZM59PoZUV92IarCP56k7I5X_QtnMDhJPDlXJLzBeBGV7Jpt5d3ZVVX27KWpJqcJkYhp5mq90zRk1ZUr3zjrj_S7sf6uAZv616Yiif0syJH5IjKON7L6rxebIpYbvW2cnmbvnLR_M5jliutsmOlokCTXMcifepSLGFs4ViKB1ZHUKVx59Szt2Cbh9iGQAN5dERXyuK3S_H2YafPtc3KA6h9vTShgdc_rzVhN1pdePPhCnvLQ3AwdQJG-WlDXcRzNzQaEhTEiPkEsQGxmaDlR9TjMi-0o8hmdPCMHPpEQuQGQ2IPyRFce4RhX-bGTH5WPsHxxm71GOqz-Wx6AqgwciMzskLLTVNrZ3qSi8vGxOTBRq6kanoKrb_1tP6bvIKGz6JwEgbxwxnsiR0V9YZO-xzq5fvH9IJ74DK9rLbuG6V8gwQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COBITOLIMOD+FOR+USE+IN+THE+TREATMENT+OF+INFLAMMATORY+BOWEL+DISEASE&rft.inventor=SANDWALL+PERNILLA&rft.inventor=KNITTEL+THOMAS&rft.inventor=ADMYRE+CHARLOTTE&rft.inventor=ZARGARI+AREZOU&rft.inventor=ZERHOUNI+PETER&rft.date=2020-01-10&rft.externalDBID=A&rft.externalDocID=CN110678188A |